Search by name, company, title, location, etc.

Dale Cooke

Member since November 2011Contact Dale

Dale Cooke is the Vice President/Group Director, Regulatory Review for Digitas Health LifeBrands and the author of the Food & Drug Law Institute's Effective Review and Approval of Digital Promotional Tactics.

Articles by Dale All articles by Dale

  • FDA Helping Pharma Operationalize Social Media in Marketing: Health on 04/11/2014

    Last year, I wrote in a Marketing:Health column, "The primary challenges for makers of prescription products with adopting social media are operational." I emphasized three sets of challenges: adverse event reporting, responsiveness, and FDA filing requirements.

  • Overcoming Social Media's Challenges in Marketing: Health on 08/09/2013

    The primary challenges with adopting social media for makers of prescription products are operational. Though much is made of the absence of an explicit Food and Drug Administration guidance on social media, we know the answer to most of the questions about the regulatory requirements for social media activity.

  • Digital Media Isn't' Risky, If Used Compliantly in Marketing: Health on 03/04/2013

    In the pharmaceutical industry, we have become accustomed to a discussion about adopting "risky" communications channels such as social media. These discussions overlook one thing: There are no risky media.

  • The FDA Social Media Guidance: The Path Forward in Marketing: Health on 02/10/2012

    In December, the FDA released the first of its long-awaited social media guidances. The collective response from industry was a shoulder shrug. So, where do we go from here?

About Edit

You haven't told us anything about yourself! Surely you've got something to say. Tell us a little something.